Table 2.

Conditions associated with developing hypophosphataemia in patients receiving parenteral iron infusions [Hardy and Vandemergel, 2015; Schouten et al. 2009; Fierz et al. 2014; Blazevic et al. 2014].

Long-term parenteral iron administration or high cumulative dose

Vitamin D deficiency

Hyperparathyroidism

Previous insufficiency fractures

Malabsorption and gut disorders (e.g. inflammatory bowel disease)

Pre-existing hypophosphataemia or related disorders

Use of polymaltose, carboxymaltose, saccharide preparations

Malnutrition

Low ferritin